Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

Blood Cancer J. 2018 Jan 29;8(1):14. doi: 10.1038/s41408-018-0050-2.

Authors

Affiliations

¹ Department of Hematology, The Ottawa Hospital, Ottawa, Canada.
² Department of Medicine, Calgary, Canada.
³ Ottawa Hospital Research Institute, Ottawa, Canada.
⁴ School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.
⁵ Canadian Blood Services Stem Cell Processing Laboratory, Ottawa, Canada.
⁶ Department of Hematology, The Ottawa Hospital, Ottawa, Canada. dawn.maze@uhn.ca.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Autografts
Benzylamines
Cyclams
Female
Graft Survival / drug effects*
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cell Transplantation*
Heterocyclic Compounds / administration & dosage*
Humans
Male
Middle Aged
Retrospective Studies
Time Factors

Substances

Benzylamines
Cyclams
Heterocyclic Compounds
plerixafor